Michael Denne is an accomplished professional in the pharmaceutical and medical affairs sectors, currently serving as Vice President of US Medical Affairs for Rare Disease and Plasma Derived Therapies at Takeda. Prior to this role, Michael held various leadership positions at Shire, including Senior Director and Director of US Hematology-Oncology Medical Affairs, as well as Director of Medical Affairs for Hemophilia at Baxter International Inc. Michael's earlier experience includes roles at P&G Pharmaceuticals, where responsibilities ranged from Therapeutic Area Manager to Medical Science Liaison, and a residency at the VA Medical Center. Academically, Michael Denne earned a Doctor of Pharmacy degree from the University of Pittsburgh between 1998 and 2004.